Xeno Transplants Stock Current Valuation
| XENO Stock | USD 0.0001 0.00 0.00% |
Valuation analysis of Xeno Transplants helps investors to measure Xeno Transplants' intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At this time, Xeno Transplants' Cash is very stable compared to the past year. As of the 11th of December 2024, Change In Cash is likely to grow to 2,596, though Total Cashflows From Investing Activities is likely to grow to (60 K). Fundamental drivers impacting Xeno Transplants' valuation include:
Price Book 10.9164 | Enterprise Value 363.3 K | Enterprise Value Ebitda (0.72) |
Overvalued
Today
Please note that Xeno Transplants' price fluctuation is very steady at this time. Calculation of the real value of Xeno Transplants is based on 3 months time horizon. Increasing Xeno Transplants' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Xeno Transplants is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Xeno Stock. However, Xeno Transplants' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 | Naive 1.0E-4 |
The intrinsic value of Xeno Transplants' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Xeno Transplants' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Xeno Transplants helps investors to forecast how Xeno stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Xeno Transplants more accurately as focusing exclusively on Xeno Transplants' fundamentals will not take into account other important factors: Xeno Transplants Company Current Valuation Analysis
Xeno Transplants' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Xeno Transplants Current Valuation | 363.27 K |
Most of Xeno Transplants' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Xeno Transplants is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Xeno Transplants has a Current Valuation of 363.27 K. This is 100.0% lower than that of the Biotechnology sector and 99.99% lower than that of the Health Care industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
Xeno Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Xeno Transplants' direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Xeno Transplants could also be used in its relative valuation, which is a method of valuing Xeno Transplants by comparing valuation metrics of similar companies.Xeno Transplants is currently under evaluation in current valuation category among its peers.
Xeno Fundamentals
| Current Valuation | 363.27 K | ||||
| Price To Earning | 3.00 X | ||||
| Price To Book | 10.92 X | ||||
| Net Income | (256.37 K) | ||||
| Cash And Equivalents | 261 | ||||
| Total Debt | 21.56 K | ||||
| Current Ratio | 0.15 X | ||||
| Book Value Per Share | 0 X | ||||
| Cash Flow From Operations | (6.56 K) | ||||
| Beta | -28.5 | ||||
| Market Capitalization | 64.58 K | ||||
| Total Asset | 641.41 K | ||||
| Retained Earnings | (46.35 K) | ||||
| Working Capital | (946 K) | ||||
| Current Asset | 100 K | ||||
| Current Liabilities | 1.05 M | ||||
| Net Asset | 641.41 K |
About Xeno Transplants Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Xeno Transplants's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Xeno Transplants using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Xeno Transplants based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Xeno Transplants
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Xeno Transplants position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xeno Transplants will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Xeno Transplants could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Xeno Transplants when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Xeno Transplants - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Xeno Transplants to buy it.
The correlation of Xeno Transplants is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Xeno Transplants moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Xeno Transplants moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Xeno Transplants can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Xeno Transplants Piotroski F Score and Xeno Transplants Altman Z Score analysis. To learn how to invest in Xeno Stock, please use our How to Invest in Xeno Transplants guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xeno Transplants. If investors know Xeno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xeno Transplants listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Xeno Transplants is measured differently than its book value, which is the value of Xeno that is recorded on the company's balance sheet. Investors also form their own opinion of Xeno Transplants' value that differs from its market value or its book value, called intrinsic value, which is Xeno Transplants' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xeno Transplants' market value can be influenced by many factors that don't directly affect Xeno Transplants' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Xeno Transplants' value and its price as these two are different measures arrived at by different means. Investors typically determine if Xeno Transplants is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xeno Transplants' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.